• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Antiserum against the conserved nine-amino-acid N-terminal peptide of influenza A virus matrix protein 2 is not immuno-protective

tetano

Editor, Senior Moderator
J Gen Virol. 2010 Oct 21. [Epub ahead of print]
Antiserum against the conserved nine-amino-acid N-terminal peptide of influenza A virus matrix protein 2 is not immuno-protective.

De Filette M, Ysenbaert T, Roose K, Schotsaert M, Roels S, Goossens E, Schepens B, Fiers W, Saelens X.

VIB-UGent;
Abstract

The recent emergence and rapid spread of the pandemic H1N1 swine influenza virus (H1N1v) reminded us once again of the need for a universal influenza vaccine that can elicit heterosubtypic protection. Here, we show the superior immunogenicity and immunoprotective capacity of the full-length matrix protein 2 ectodomain (M2e) peptide coupled to keyhole limpet hemocyanin (KLH) compared to the N-terminal nine amino acid residues of M2e (SP1). Immunization with M2e-KLH protected mice against a lethal challenge with influenza A virus and significantly reduced weight loss and lung virus titres. In addition, passive transfer of serum raised in rabbits against M2e-KLH protected mice against a lethal influenza virus challenge, whereas serum from rabbits immunized with SP1-KLH did not. Nevertheless, immunofluorescence staining revealed that rabbit serum raised against SP1-KLH bound specifically to infected MDCK cells. We conclude that the peptide SP1 contains an immunogenic epitope that is not sufficient for immunoprotection.

PMID: 20965983 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/20965983
 
Back
Top Bottom